PANews reported on March 25th that Ella Zhang, head of YZi Labs, stated in an article on the X platform that YZi Labs invests broadly in Web3, AI, and biotechnology, with the majority of investments being in equity rather than token form. For portfolio projects that haven't yet found product-market fit, YZi Labs advises founders to focus on achieving product-market fit rather than rushing to issue tokens, as tokens lacking sustainable utility will eventually lose value, and issuing tokens often becomes a distraction and a burden.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact
[email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.